R. Carruthers
Financieel Directeur/CFO bij EDGEWISE THERAPEUTICS, INC.
Vermogen: 561 566 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Kevin Koch | M | 63 | 23 jaar | |
| Anthony D. Piscopio | M | - |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 22 jaar |
| Robert Conway | M | 70 |
ClinOne, Inc.
 ClinOne, Inc. Packaged SoftwareTechnology Services ClinOne, Inc. develops mobile software application. The firm serves for sites and patients. It offers elaerning, screening, documents, videos, econsent, procedure manager, and adverse events services. The company was founded by Rob Bohacs and Eric Schraufnagel and is headquartered in Denver, CO. | 21 jaar |
| John Moore | M | 59 |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 20 jaar |
| Xuedong Liu | M | - |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 13 jaar |
| Joseph Ferra | M | 49 | 3 jaar | |
| Badreddin Edris | M | 37 | 7 jaar | |
| James Rickey | M | 45 | 7 jaar | |
| Nicholas A. Saccomano | M | 65 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 6 jaar |
| Alan Russell | M | 54 | 7 jaar | |
| Steven Elms | M | 60 | 5 jaar | |
| Peter Thompson | M | 64 | 7 jaar | |
| Aaron Fox-Collis | M | - | 4 jaar | |
| Tammy Furlong | F | - | - | |
| Stanford Peng | M | 53 | 7 jaar | |
| Andrew Phillips | M | 53 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 4 jaar |
| Jon Root | M | 64 | 5 jaar | |
| Darcy Mootz | M | - | - | |
| Jonathan Fox | M | 66 | 1 jaar | |
| Maurice A. Gaubatz | M | - |
Pyxant Labs, Inc.
 Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | 24 jaar |
| Mitchell Gold | M | 57 | 7 jaar | |
| Timothy Clackson | M | 58 | 4 jaar | |
| Laura Brege | F | 66 | 4 jaar | |
| Candice Masse | F | - | - | |
| Joanne Donovan | M | 67 | 3 jaar | |
| Marc Semigran | M | 67 | 2 jaar | |
| Isaac Manke | M | 47 |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 3 jaar |
| Thaedra Thullberry | F | - | 7 jaar | |
| Jerrod Langley | M | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | 18 jaar |
| John DeMattei | M | - |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | - |
| Guobao Zhao | M | - |
OnKure, Inc.
OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | 7 jaar |
| David Dornan | M | 46 | 2 jaar | |
| Behrad Derakhshan | M | 44 | 4 jaar | |
| Leslie Leinwand | M | - | - | |
| Valerie Jansen | M | 46 | - | |
| Kimberly Milazzo | F | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | 18 jaar |
| Robert Yang | M | - | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jon Congleton | M | 60 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 3 jaar |
| Shawn Leland | M | 40 | 4 jaar | |
| Robert G. Kuhbach | M | 76 | 16 jaar | |
| Jay Venkatesan | M | 52 | 5 jaar | |
| Liam Ratcliffe | M | 60 | 2 jaar | |
| Gil van Lunsen | M | 81 | 17 jaar | |
| Robert Brown | M | 62 | 4 jaar | |
| Cynthia Smith | F | 55 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 jaar |
| Evan Loh | M | 65 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 5 jaar |
| Charles Baum | M | 65 | 5 jaar | |
| Andrew Robbins | M | 48 | 7 jaar | |
| Lori Hu | F | 38 | 5 jaar | |
| John Robinson | M | 50 | - | |
| David McAvoy | M | 62 | 4 jaar | |
| Kenneth Harrison | M | 44 | 4 jaar | |
| Colin Walsh | M | 38 | 4 jaar | |
| Gwen A. Fyfe | M | 72 | 7 jaar | |
| Paul Sekhri | M | 65 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 jaar |
| Ron Squarer | M | 57 | 7 jaar | |
| John L. Zabriskie | M | 85 | 12 jaar | |
| Thomas L. Reece | M | 81 | 15 jaar | |
| Francis J. Bullock | M | 87 | 14 jaar | |
| John Orwin | M | 62 | 7 jaar | |
| William D. Ju | M | 67 | 6 jaar | |
| Gary M. Clark | M | - | - | |
| David Rodman | M | 69 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 1 jaar |
| Sanjeev Ahuja | M | - | 1 jaar | |
| Adam Levy | M | 46 | - | |
| Marvin H. Caruthers | M | 84 | 13 jaar | |
| Jonathan Leff | M | 55 |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | 2 jaar |
| Eli M. Wallace | M | 57 | 11 jaar | |
| Richard Gaster | M | 40 | 2 jaar | |
| Victor Sandor | M | 57 | 5 jaar | |
| Sahil Chopra | M | - | 1 jaar | |
| David J. Horin | M | 56 | - | |
| William Spurgeon | M | 65 | 26 jaar | |
| Brad Barnett | M | - | 19 jaar | |
| Amy C. Cavers | F | - | - | |
| Mark R. Miglarese | M | - | 2 jaar | |
| Robert W. Overell | M | 69 | 4 jaar | |
| John Josey | M | 63 | 13 jaar | |
| Douglas Williams | M | 66 | 7 jaar | |
| James D. Winkler | M | - | - | |
| David A. Robaugh | M | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | - |
| Bengt Bergstrom | M | - | - | |
| Janice Troha | F | - | - | |
| Tom Sokolowski | M | - |
Nivalis Therapeutics, Inc.
Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO. | - |
| Frank Pallas | M | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | - |
| Karsten Witt | M | 68 | 2 jaar | |
| Nicolas Gilmour | M | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | - |
| Robert E. Winkler | M | 58 | - | |
| George Abercrombie | M | 69 | 10 jaar | |
| Michael N. Needle | M | 64 | 1 jaar | |
| Melissa Gaubatz | F | - |
Pyxant Labs, Inc.
Pyxant Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Pyxant Labs, Inc. provides bio analytical development services. It offers metabolism and toxicology bio analytical support, pharmaceutical & bioequivalence support, impurities characterization, fingerprinting and isolation, storage stability for formulations and biological matrices and formulations development analytical support services. The company was founded by Maurice A. Gaubatz in 2000 and is headquartered in Colorado Springs, CO. | - |
| Patrice Lee | M | - | - | |
| Howard T. Holden | M | - | - | |
| John Yates | M | 67 | 1 jaar | |
| Julie VanOrsdel Daves | F | - | 3 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 95 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- R. Carruthers
- Persoonlijk netwerk
